Insulin	O
-	O
like	O
growth	O
factor	O
1	O
receptor	O
enhances	O
invasion	O
and	O
induces	O
resistance	O
to	O
apoptosis	O
of	O
colon	B-Cell
cancer	I-Cell
cells	I-Cell
through	O
the	O
Akt	O
/	O
Bcl	O
-	O
x	O
(	O
L	O
)	O
pathway	O
.	O

Colon	B-Cancer
cancer	I-Cancer
overexpresses	O
insulin	O
-	O
like	O
growth	O
factor	O
1	O
(	O
IGF1	O
)	O
and	O
insulin	O
-	O
like	O
growth	O
factor	O
1	O
receptor	O
(	O
IGF1	O
-	O
R	O
)	O
,	O
as	O
compared	O
with	O
normal	O
or	O
adenomatous	B-Multi-tissue_structure
mucosa	I-Multi-tissue_structure
,	O
and	O
it	O
has	O
been	O
postulated	O
that	O
colorectal	B-Cell
cancer	I-Cell
cells	I-Cell
depend	O
on	O
the	O
IGF1	O
/	O
IGF1	O
-	O
R	O
pathway	O
for	O
their	O
growth	O
and	O
progression	O
.	O

In	O
this	O
study	O
,	O
using	O
the	O
human	O
colon	B-Cell
cancer	I-Cell
cell	I-Cell
line	I-Cell
HCT116	I-Cell
,	O
we	O
find	O
that	O
established	O
HCT116	B-Cell
/	I-Cell
IGF1	I-Cell
-	I-Cell
R	I-Cell
transfectants	I-Cell
exhibit	O
a	O
more	O
aggressive	O
transformed	O
phenotype	O
than	O
the	O
parental	B-Cell
cell	I-Cell
line	I-Cell
,	O
as	O
demonstrated	O
by	O
their	O
higher	O
proliferation	O
rate	O
in	O
response	O
to	O
IGF1	O
,	O
higher	O
degree	O
of	O
anchorage	O
-	O
independent	O
growth	O
,	O
resistance	O
to	O
serum	B-Organism_substance
deprivation	O
-	O
induced	O
apoptosis	O
,	O
and	O
higher	O
migratory	O
capability	O
in	O
a	O
monolayer	B-Cell
"	O
wounding	O
assay	O
.	O
"	O
When	O
injected	O
into	O
nude	O
mice	O
,	O
HCT116	B-Cell
/	I-Cell
IGF1	I-Cell
-	I-Cell
R	I-Cell
transfectants	I-Cell
were	O
highly	O
invasive	O
and	O
produced	O
distant	O
metastases	B-Cancer
,	O
whereas	O
the	O
parental	B-Cell
cell	I-Cell
did	O
not	O
.	O

Moreover	O
,	O
the	O
overexpression	O
of	O
IGF1	O
-	O
R	O
in	O
these	O
cells	B-Cell
was	O
associated	O
with	O
IGF1	O
-	O
R	O
-	O
induced	O
activation	O
of	O
Akt	O
and	O
up	O
-	O
regulation	O
of	O
the	O
antiapoptotic	O
protein	O
Bcl	O
-	O
x	O
(	O
L	O
)	O
.	O

We	O
also	O
show	O
that	O
Akt	O
pathway	O
mediates	O
IGF1	O
-	O
R	O
-	O
induced	O
Bcl	O
-	O
x	O
(	O
L	O
)	O
expression	O
at	O
transcriptional	O
level	O
.	O

Our	O
data	O
demonstrate	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
IGF1	O
-	O
R	O
/	O
Akt	O
/	O
Bcl	O
-	O
x	O
(	O
L	O
)	O
pathway	O
may	O
contribute	O
to	O
a	O
more	O
aggressive	O
malignant	O
phenotype	O
,	O
in	O
a	O
subset	O
of	O
colorectal	B-Cancer
cancers	I-Cancer
.	O

